Publications - Navtej S . Buttar, M.D.
Back to Research Profile
- Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 2009 Sep; 137(3):815-23. Epub 2009 Jun 12.
View PubMed
- Wang KK, Lutzke L, Borkenhagen L, Westra W, Song MW, Prasad G, Buttar NS. Photodynamic therapy for Barrett's esophagus: does light still have a role? Endoscopy 2008 Dec; 40(12):1021-5. Epub 2008 Dec 08.
View PubMed
- Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Westra WM, Lutzke LS, Borkenhagen LS, Dunagan K. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer 2008 Aug 1; 113(3):470-6.
View PubMed
- Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Fritcher EG, Westra WM, Krishnadath KK, Lutzke LS, Borkenhagen LS. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology 2008 Aug; 135(2):370-9. Epub 2008 May 07.
View PubMed
- Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Barr Fritcher EG, Westra WM, Krishnadath KK, Lutzke LS, Borkenhagen LS. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.[see comment]. Gastroenterology 2008 Aug; 135(2):370-9.
View PubMed
- Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res 2008 Apr 15; 68(8):2632-40.
View PubMed
- Ilyas S, Demars CJ, Buttar NS. Chemoprevention in Barrett's Esophagus. Int J Gastrointest Cancer 2008 Jan 03. [Epub ahead of print]
View PubMed
- Milano F, Rygiel AM, Buttar N, Bergman JJ, Sondermeijer C, van Baal JW, ten Brinke A, Kapsenberg M, van Ham SM, Peppelenbosch MP, Krishnadath KK. An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer. Cancer Immunol Immunother 2007 Dec; 56(12):1967-77. Epub 2007 Jun 13.
View PubMed
- Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol 2007 Nov; 102(11):2380-6. Epub 2007 Jul 19.
View PubMed
- Song S, Guha S, Liu K, Buttar NS, Bresalier RS. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2007 Nov; 56(11):1512-21. Epub 2007 Jun 29.
View PubMed
- Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, Rosmolen WD, Bergman JJ, VAn Marle J, Wang KK, Peppelenbosch MP, Krishnadath KK. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 2007 Jun; 132(7):2412-21. Epub 2007 Mar 19.
View PubMed
- Prasad GA, Wang KK, Baron TH, Buttar NS, Wongkeesong LM, Roberts LR, LeRoy AJ, Lutzke LS, Borkenhagen LS. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 2007 Jun; 5(6):743-8.
View PubMed
- Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, Lutzke LS, Borkenhagen LS. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007 Apr; 132(4):1226-33.
View PubMed
- Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Lutzke LS, Borkenhagen LS. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2007 Jan; 65(1):60-6.
View PubMed
- Ilyas S, DeMars CJ, Buttar NS. Chemoprevention in Barrett's esophagus. J Gastrointest Cancer 2007; 38(1):1-9.
View PubMed
- Buttar NS, Fernandez-Zapico ME, Urrutia R. Key role of Kruppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasias. Curr Opin Gastroenterol 2006 Sep; 22(5):505-11.
View PubMed
- Prasad GA, Wang KK, Lutzke LS, Lewis JT, Sanderson SO, Buttar NS, Song LMWK, Borkenhagen LS, Burgart LJ. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus. Clin Gastroenterol Hepatol 2006 Feb; 4(2):173-8.
View PubMed
- Prasad GA, Wang KK, Lutzke LS, Lewis JT, Sanderson SO, Buttar NS, Wong Kee Song LM, Borkenhagen LS, Burgart LJ. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus. Clin Gastroenterol Hepatol 2006 Feb; 4(2):173-8.
View PubMed
- Buttar NS, Wiersema MJ, Wang KK, DeMars CJ, Prasad GA, Lutzke LS. Rodent endosonography to monitor esophageal cancer. International Journal of Gastrointestinal Cancer 2006; 37(2-3):84-90.
View PubMed
- Maple JT, Petersen BT, Baron TH, Gostout CJ, Wong Kee Song LM, Buttar NS. Direct percutaneous endoscopic jejunostomy: Outcomes in 307 consecutive attempts. Am J Gastroenterol 2005 Dec; 100(12):2681-8.
View PubMed
- Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005 May; 128(5):1471-505.
View PubMed
- Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005 May; 128(5):1468-70.
View PubMed
- Buttar NS, Wang KK. Mechanisms of disease: Carcinogenesis in Barrett's esophagus. Nature Clinical Practice Gastroenterology & Hepatology 2004 Dec; 1(2):106-12.
View PubMed
- Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2003 Jul; 1(4):252-7.
View PubMed
- Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002 Apr; 122(4):1101-12.
View PubMed
- Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, Lutzke LS. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst 2002 Mar 20; 94(6):422-9.
View PubMed
- Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001 Dec; 54(6):682-8.
View PubMed
- Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001 Jun; 120(7):1630-9.
View PubMed
- Kendrick ML, Buttar NS, Anderson MA, Lutzke LS, Peia D, Wang KK, Sarr MG. Contribution of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding. J Gastrointest Surg 2001 Mar-Apr; 5(2):162-7.
View PubMed
- Buttar NS, Falk GW. Pathogenesis of gastroesophageal reflux and Barrett esophagus. Mayo Clin Proc 2001 Feb; 76(2):226-34.
View PubMed
- Buttar NS, Wang KK. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. Mayo Clin Proc 2000 Oct; 75(10):1027-38.
View PubMed
- Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, Lutzke LS, Liu W. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000 Sep; 119(3):624-30.
View PubMed
|